Open AccessMatrix Metalloproteinase-9 in an Exploratory Trial of Intravenous Minocycline for Acute Ischemic Stroke
Author(s) -
Jeffrey A. Switzer,
David C. Hess,
Adviye Ergul,
Jennifer L. Waller,
Sandro Lemos Machado,
Vera PortikDobos,
L. Creed Pettigrew,
Wayne M. Clark,
Susan C. Fagan
Publication year - 2011
Publication title -
stroke
Language(s) - English
Resource type - Journals
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.111.618215
Subject(s) - medicine , minocycline , stroke (engine) , ischemic stroke , matrix metalloproteinase 9 , acute stroke , anesthesia , ischemia , matrix metalloproteinase , antibiotics , mechanical engineering , tissue plasminogen activator , microbiology and biotechnology , biology , engineering
Plasma matrix metalloproteinase-9 levels predict posttissue plasminogen activator (tPA) hemorrhage.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom